European pharma stocks decline as Trump reiterates tariff plans
Source: SeekingAlpha
2025-04-09 06:02:04 ET
More on European drugmakers
- Novartis After Sandoz: The Business Without Generics
- AstraZeneca's Innovation Ecosystem: From Blockbusters To The Next Generation Of Therapy
- Novo Nordisk: Not As Bullish As Many
- Daiichi Sankyo and AstraZeneca get EU approval for Datroway
- Novo reportedly eyeing $1.09B investment in Brazil to expand obesity drug production
Read the full article on Seeking Alpha
For further details see:
European pharma stocks decline as Trump reiterates tariff plans
UCB SA
NASDAQ: UCBJF
UCBJF Trading
0.0% G/L:
$299.45 Last:
1 Volume:
$299.45 Open:
